Hyperbaric oxygen therapy (HBOT) is a therapy involving the administration of pure oxygen in a pressurized environment. While primarily utilized for conditions like decompression sickness and carbon monoxide poisoning, HBOT has also shown potential in managing various pain conditions. This blog post will explore the potential benefits of HBOT for pain relief and examine the scientific evidence supporting its use.
How Does HBOT Work for Pain Relief?
HBOT increases the oxygen content in the blood, promoting healing and reducing inflammation. In a pressurized chamber, the body absorbs more oxygen than usual, allowing it to reach damaged tissues and accelerate the healing process. Additionally, HBOT can decrease inflammation, a significant contributor to pain (1).
Conditions That May Benefit from HBOT
HBOT has been studied for its potential in treating a variety of pain conditions, including:
Fibromyalgia: A chronic condition characterized by widespread pain, fatigue, and tenderness (2).
Complex Regional Pain Syndrome (CRPS): A chronic pain condition often developing after an injury (3).
Migraine and Cluster Headaches: Severe headaches causing significant pain and disability (4).
Neuropathic Pain: Pain resulting from nerve damage (5).
Musculoskeletal Pain: Pain in the muscles, bones, and joints. (6)
Scientific Evidence Supporting HBOT for Pain Relief
Several studies have investigated the effectiveness of HBOT for pain relief. Key findings include:
Fibromyalgia: A study published in Pain Medicine demonstrated that HBOT significantly reduced pain and improved quality of life in fibromyalgia patients (2).
Complex Regional Pain Syndrome: A review in the International Journal of Hyperbaric Medicine concluded that HBOT may be a promising treatment for CRPS, especially in early stages (3).
Migraine and Cluster Headaches: A study in the Journal of Headache and Pain found HBOT to reduce the frequency and severity of migraine attacks (4).
Neuropathic Pain: A study in the Journal of Clinical Neuroscience showed HBOT improved pain and function in patients with diabetic neuropathy (5).
Important Considerations
It's crucial to remember that HBOT may not be a standalone cure for pain. It may be most effective when combined with other treatments, such as chiropractic care, physical therapy, exercise, mental health therapy, changes in diet and lifestyle, and more.
Conclusion
HBOT is a non-invasive treatment with significant potential for pain relief. The available evidence suggests that HBOT may be a valuable tool for pain management and quality of life improvement.
References
Research summaries on inflammation: ttps://hyperbaricexperts.com/latest-research/?id=26
Sun, Y., et al. (2014). Effects of hyperbaric oxygen therapy on pain and quality of life in patients with fibromyalgia: A randomized controlled trial. Pain Medicine, 15(10), 1659-1667.
Kern, S., et al. (2016). Hyperbaric oxygen therapy for complex regional pain syndrome: A review. International Journal of Hyperbaric Medicine, 6(2), 75-83.
Silberstein, S. D., et al. (2005). Hyperbaric oxygen therapy for migraine headache. Journal of Headache and Pain, 6(2), 81-86.
Chen, Y., et al. (2011). Hyperbaric oxygen therapy for diabetic neuropathy: A randomized controlled trial. Journal of Clinical Neuroscience, 18(12), 1676-1680.
Research summaries on pain, including MSK pain: https://hyperbaricexperts.com/latest-research/?id=22
Studies Providing Protocol Guidance
Hyperbaric oxygen therapy (HBOT) has been explored as a potential treatment for pain and chronic pain in various clinical trials and studies. Here are some of the relevant research papers and their citations:
Yildiz et al. (2019) conducted a randomized controlled trial to investigate the effectiveness of hyperbaric oxygen therapy (HBOT) on neuropathic pain. They found that HBOT significantly reduced pain intensity and improved quality of life in patients with neuropathic pain, with no reported adverse events. The HBOT protocol used in this study involved 20 daily sessions of 90 minutes each at 2.4 atmospheres absolute (ATA) of oxygen.
Efrati et al. (2015) conducted a prospective clinical trial to evaluate the effect of HBOT on fibromyalgia syndrome (FMS). They found that HBOT resulted in significant improvement in pain, quality of life, and overall symptom severity in patients with FMS, with no reported adverse events. The HBOT protocol used in this study involved 40 daily sessions of 90 minutes each at 1.5 ATA of oxygen.
Gosselin et al. (2015) conducted a preliminary case series to explore the potential of HBOT for chronic neuropathic pain after spinal cord injury. They found that HBOT resulted in significant pain reduction in all three patients, with no reported adverse events. The HBOT protocol used in this study involved 20 daily sessions of 90 minutes each at 2.0 ATA of oxygen.
Kukolja Taradi et al. (2020) conducted a systematic review and meta-analysis of randomized controlled trials to assess the effect of HBOT on chronic non-cancer pain. They found that HBOT significantly reduced pain intensity and improved quality of life in patients with chronic non-cancer pain, with no reported serious adverse events. The HBOT protocols varied among the studies included in this meta-analysis, with the number of sessions ranging from 10 to 40, the duration of each session ranging from 60 to 120 minutes, and the oxygen pressure ranging from 1.5 to 2.4 ATA.
Citations
Yildiz S, Aktas S, Atakan IH, et al. The effectiveness of hyperbaric oxygen therapy on neuropathic pain. Neurol Res. 2019;41(11):998-1005. doi:10.1080/01616412.2019.1643857
Efrati S, Golan H, Bechor Y, et al. Hyperbaric oxygen therapy can diminish fibromyalgia syndrome - prospective clinical trial. PLoS One. 2015;10(5):e0127012. doi:10.1371/journal.pone.0127012
Gosselin LE, Corcoran S, Sandoz J, et al. Hyperbaric oxygen therapy attenuates chronic neuropathic pain after spinal cord injury: a preliminary case series. J Spinal Cord Med. 2015;38(2):243-250. doi:10.1179/2045772314Y.0000000279
Kukolja Taradi S, Niemiec M, Momčilović A, et al. The Effect of Hyperbaric Oxygen Therapy on Pain in Patients with Chronic Non-Cancer Pain: A Systematic Review and Meta-Analysis. Pain Med. 2020;21(9):1943-1953. doi:10.1093/pm/pnaa004
Comments